Asia Pacific Medical Robot Market, Market Research Report, Industry Research Report, Analysis, Size: Ken Research

Posted January 7, 2019 by kenresearch123

Medical robots are that robots, which are used for remotely operating computers for accessing information.

According to study, “Asia-Pacific Medical Robot Market (2018-2023)” some of the major companies that are currently working in the Asia-Pacific medical robot market are Omnicell Inc., Ekso Bionics Holdings Inc., Titan Medical, Rewalk Robotics, Baxter International, Abbot Diagnostics, Carefusion, Elekta, Kirby Lester LLC, Apex Automation and Robotics, Intuitive Surgical, Aurora Biomed, Roche Holdings AG, Hansen Medical Inc., Biotek Instruments, Stanmore Implants Worldwide, IRobot Corp., KUKA, Midea-Yaskawa, Shenzhen Sanggu, Honda Robotics, Agilent Technologies, Toyota, Beijing Tinavi, Stryker Corporation, Cyberdyne, Aesynt, Daihen Corp, Mazor Robotics Ltd., Renishaw Plc., Nikkei, Beijing Bohuiweikang Technology, Arxium, Accuray Inc., Chongqing Jinshan Science and Technology, Varian, Ossur, Hocoma AG.
Medical robots are that robots, which are used for remotely operating computers for accessing information. They restore or adjust patient’s body function or a body part. The medical robots provide modern analytical facilities and highest possible comfort for the patients. It also adds the competences and facilities for performing smaller and new specific as well as correct invasions. Medical robots are categorized into surgical robots, biorobots, telepresence robots, rehabilitation robots, disinfection robots, companion robots and pharmacy automation robots etc. Main features are less blood loss, smaller scars, faster recovery, less pain, accuracy and shorter hospital stay etc. Some important medical robots are the Da Vinci Surgical Robot and ViRob Miniature medical robot.
On the basis of component, the medical robot market is segmented into user interface, visualization system, locomotion systems, software platform, power sources and safety systems etc. On the basis of product, the market is segmented into rehabilitation robot, instruments & accessories, surgical robot, non-invasive radio surgery robot and others. Rehabilitation robots are further sub-segmented into prosthetic robots, exoskeleton robots, therapeutic robot and assistive robots etc. Surgical robots are made up of cardiology surgery robotic systems, orthopedic surgical robotic systems, laparoscopic surgical robotic systems, neurological surgery robotic systems and steerable robotics. In addition, hospital and pharmacy automation robots are consist by telemedicine Robots, IV robots and pharmacy automation robots. On the basis of application, the market is segmented into orthopedic, laparoscopy, neurology and cardiology etc.
The Asia-Pacific medical robot is mainly driven by huge population followed by rising awareness and growing hospital investments in medical robots, and increasing prevalence of diseases, development of new technologies advancements, increasing in funding for medical robots research and government regulation and policies etc. Growth of the market can primarily be attributed to robot-assisted training in rehabilitation therapy, increase in funding for medical robot research, and the issuance of IPOs by medical robot companies.
Apart from advantages, some of the challenges include lack of logistic facilities, lack of transportation, increasing cost of treatment etc.
In India, healthcare industry is in very tough situation owing to goods and services tax (GST). GST is responsible for high cost of necessary healthcare facilities such as various health treatment and hospital room rent etc. The inadequate distribution of healthcare services in small pockets is foremost threat of market.
Japan, China and India are three key countries that have helped in the development of medical robotics market in the Asia Pacific region. These countries are starting many startups to deliver higher care systems for surgeries and cures. It is expected that Asia-Pacific medical robot market will be reached at 3.4 billion, at a CAGR of 18.7%, by 2023.
To know more, click on the link below:
Related Reports :
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Ken Research
Phone 01244230204
Country India
Categories Health
Last Updated January 7, 2019